

Cover Story
FreeObituary
John Mark Cleland died peacefully on Feb. 7, 2022, in Indianapolis. Some people reading this headline will have little or no idea who John Cleland was. However, if you are a medical or urological oncologist, you should. John Cleland was the first man whose metastatic testicular cancer was cured with combination chemotherapy containing cisplatin.
Black History MonthCancer History ProjectFree
By Alexandria Carolan and Alice Tracey
In Brief


Clinical Roundup


Trending Stories
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Peter F. Garrett to people with cancer: Your story has power
- OMB proposed rule could end 50% of currently active clinical trials, Stand up for Science analysis finds
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.” - What NHS-Galleri taught us—and what it didn’t
- The NHS-Galleri trial has and will continue to provide critical insights to refine future MCED studies

















